Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NGNE

Neurogene Inc.

CIK 0001404644 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$38.63
↑ 0.64 (1.68%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$773.04M
P/E Ratio
-6.96
EPS
-4.24
Dividend Yield
Not covered
52W Position
82%
Beta
1.53

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.56
P/S
Not covered
EV/Revenue
Not covered
ROE
-51.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 82%
$15.93$43.66

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$90.35M
Total Assets
$288.60M
Free Cash Flow
-$78.36M

Recent news